‘Bayer For Her’ Supporting 365 Days Conversations of Care to More Women in Asia

Bridging the gap on lack of discussion amongst Asian women on their health concerns this World Contraception Day (WCD)

SINGAPORE, Sept. 27, 2023 /PRNewswire/ — Bayer Pharmaceuticals Division in Asia/Pacific announced today in conjunction with World Contraception Day, the inception of its ‘Bayer For Her’ regional campaign that has been piloted first in Thailand since September 2022. The campaign has since rolled out to Singapore, South Korea, Taipei City and rest of ASEAN markets including Indonesia, Malaysia, the Philippines and Vietnam.


‘Bayer For Her’ is not an awareness campaign but a call to action for women in Asia to share #ConversationsofCare about their own health issues – ranging from contraception to endometriosis and menstrual pain or heavy menstrual bleeding – and talk to a healthcare professional about them. The social stigma women face at home and in the workplace often result in a lot of stress and shame. ‘Bayer For Her’ advocates local health screenings in above countries, menstrual and psychological support to employees, as well as flexible working policies at all levels.

Asian women living in Singapore appear to be more prone to deep infiltrating endometriosis, with higher levels of bleeding during menstruation, than their Western counterparts.[1] In Singapore, menstrual issues have emerged as one of the top concerns, with eight in 10 women being affected by such conditions, according to a Doctor Anywhere and Bayer Women’s Health Survey.[2]

According to Guttmacher Institute, almost 132 million women of reproductive age in Asia have an unmet need for modern contraception that is, they want to avoid a pregnancy but are either not practicing contraception or are using traditional methods, which are less effective than modern methods.[3] The ability for women to choose how many children they want, if at all, and when they want to have them is central to women’s empowerment and sustainable development in achieving the United Nations Sustainability Development Goals. For all these reasons, Bayer has set the goal to provide education to 100 million women in low- and middle-income countries on access to family planning by 2030.

Improving women’s health, rights and economic status is a large step towards increasing gender equality. As women take center stage in various aspects of society, including leadership roles and making family health decisions, there is increasing need to address their unique health concerns and provide tailored approach to such unmet needs. Also, as women take on multiple roles and as carers, they often focus so much on taking care of others that they forget to prioritize their own health.

‘Bayer For Her’ is championing locally for women to find their best avenues to reach out to healthcare professionals, friends and family and not suffer in silence. The campaign which has been shortlisted as a Finalist in the SABRE Awards APAC 2023 has gained traction over the past year – with over 18 local partners/NGOs in eight countries and thousands of healthcare professionals and Bayer employees joining the cause.

Here’s a snapshot of the milestones:


Bayer Indonesia employees sharing their Endometriosis journey in a Linkedin video.

Indonesia

In partnership with National Family Planning Coordinating Board (BKKBN) and Indonesia Midwives Association, several livestreams via Bicara Kontrasepsi and BKKBN Instagram were organized to reach out to women on the topic of contraception. An “EmpowerHer” sport employee activity with social media campaign and a serial women’s healthcare talks with Healthcare Professional were conducted to spread the campaign. In March, two local employees were featured on Bayer’s Linkedin video series to share their personal journey living with Endometriosis.


Ask Maya education series by Bayer Malaysia

Malaysia

In addition to its existing Ask Maya education series on Meta, Bayer is collaborating with the National Population and Family Development Board to drive awareness and knowledge on the importance of family planning and benefits of contraception use. In the “Choose with Confidence” campaign which will be held throughout September this year, qualified women in the low-income family will have access to counselling and subsidized contraceptive at selected Nur Sejahtera clinics under the National Population and Family Development Board to help address cost-related barriers especially to high-risk groups.


Panel of speakers sharing conversations of care at launch event in the Philippines.

Philippines

‘Bayer For Her’ was launched in the Philippines in August with an initial campaign with a series of free pop-up consultation clinics at selected partner drug stores to encourage more women seek out expert advice on reproductive health. These pop-up clinics through local pharmacy partners aimed at helping create safe spaces for women to speak up and normalize conversations about their reproductive health concerns, as well as break down barriers or common misconceptions on why they do not consult with their doctors to get the support they need. Content creator and reproductive health advocates Say Tioco, Verniece Enciso and former professional volleyball player Melissa Gohing-Nacino also used the platform to spread conversations of care.


Bayer collaborates with Doctor Anywhere in Singapore to understand women’s health concerns.

Singapore

GP doctors are usually the first point of contact for women’s health and preventative medical care thus Bayer partnered with telehealth provider Doctor Anywhere (DA) to conduct a women’s health survey (Conversations of Care) in 2022 to 1,212 Asian women in Singapore. Through this effort, Bayer seeks to understand their views on a range of topics from contraception to cancer, and menstrual health. The survey gathered women’s anonymous feedback on their top health concerns, one of the key findings hit home; Co-workers/colleagues were singled out as least understanding of concerns around female health, and consequently women felt uncomfortable talking to co-workers/colleagues about their female health. As part of our internal launch, the survey reminded female colleagues in the office to take charge of their health with regular checks and screenings while also  encouraging all colleagues to support one another on their health concerns at the workplace through company initiatives backed by HR policies. 


Heavy Menstrual Bleeding checklist introduced to Bayer Korea employees and participating clinics.

South Korea

Bayer Korea developed a key indicator, MVPT, for monitoring menstrual health and conducted a survey for 1,000 Korean women on their menstrual symptoms and impact on daily life. Leveraging the survey result as infographic including a heavy menstrual bleeding (HMB) self-checklist on the nation’s leading chat platform KakaoTalk channel and also SNS (IG, Blogs) through a collaboration with influencers which resulted in over 3,659,102 views. In addition, the educational posters with self-checklist and disease information were distributed to 600 clinics nationwide with QR code for patients’ easy access to information on HMB, estimated to affect one in three women.


Bayer Taiwan uniting stakeholder groups through cycling to break down discrimination against menstrual pain.

Taipei City

Over 60 employees and healthcare professionals from its medical society and NGO HOPE Foundation, Taiwan pedaled off ‘Bayer For Her’ by cycling 60km around Taipei city to form the shape of a uterus in a bid to #breakdiscrimination, urging women to # #DoNotLiveWithPain. The physical activation resulted in a call to action for women to download the QR code for an endometriosis checker that would lead them through geofencing to their nearest location of the linked OBGYNs at medical centers and regional hospitals. The campaign not only aimed at increasing awareness of endometriosis and increasing early diagnosis but also created a positive outlook for women to embrace.


‘Bayer For Her’ was first launched in Thailand and reached out to more than 3 million women.

Thailand

Piloting ‘Bayer For Her’ on WCD2022 in partnership with the Department of Health’s Bureau of Reproductive Health and the Planned Parenthood Association of Thailand (PPAT) under the Patronage of H.R.H. Princess Mother, Thailand hosted a series of “Breaking Myths” educational events online and at Siam Square. Together with pharmacy chains Bangkok Drugstore, Boots Pharmacy and P&F, women in Thailand can continue to gain access to proper contraception information. Further working with digital thought leaders including physicians and pharmacists, a 3-month TikTok campaign was initiated to drive local #ConversationsofCare, boosted by local hero videos on Meta channels including “Pantip”. 


France-Vietnam OBGYN Conference provided a platform to showcase Vietnam’s ‘Science for Her’.

Vietnam

Grounded in science, Vietnam’s ‘Science for Her’ platform unites its Pharmaceuticals and Consumer Health divisions to address women’s wide range of healthcare needs across all life stages. Through strategic partnerships with the signing of two Memorandum of Understanding (MOU) at National Hospital of Obstetrics and Gynecology and Hung Vuong Hospital and a France-Vietnam OBGYN Conference attended by over thousands of delegates, Bayer Vietnam aims to foster collaborations with international OBGYN organizations and experts to enable knowledge transfer and information exchange with local medical community. In consumer outreach, tailored activities with two leading pharmacy chains and livestreams empower women on selfcare, active lifestyle and disease prevention. Bayer Vietnam has been partnering with the General Office of Population and Family Planning of the Ministry of Health to provide better care and access for Vietnamese women for eight consecutive years.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.com.

Find more information at https://pharma.bayer.com/ 

Follow us on Facebook: http://www.facebook.com/bayer 

Follow us on Twitter: @BayerPharma

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

MA-PF-WHC-SG-0011-1

[1] Health Xchange SG, Endometriosis: Asian Women May Be at Higher Risk, SingHealth Group https://www.healthxchange.sg/women/urology/endometriosis-asian-women-higher-risk

[2] Women’s Health Survey 2022 conducted by Doctor Anywhere and Bayer https://doctoranywhere.com/womens-health-survey-2022/

[3] Guttmacher Institute, Abortion Worldwide 2017: Uneven Progress and Unequal Access, Susheela Singh et al, March 2018 https://www.guttmacher.org/report/abortion-worldwide-2017

 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.